Giulia Mammone | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?	EUROPEAN UROLOGY ONCOLOGY	2024
The role of opioids in cancer response to immunotherapy	JOURNAL OF TRANSLATIONAL MEDICINE	2021
Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era	JOURNAL OF TRANSLATIONAL MEDICINE	2021
3MO Oncogenic non-G12C {KRAS} mutations in {KRAS} G12C mutated lung adenocarcinomas in {TRACERx} and {GENIE}: A reservoir for intrinsic resistance to {KRAS} G12C inhibitors	ANNALS OF ONCOLOGY	2021
The impact of locoregional treatment on response to Nivolumab in advanced platinum refractory head and neck cancer: the NEED TRIAL	VACCINES	2020
Comparative effects of Folfirinox and Gemcitabine/nab-paclitaxel as first and second line chemotherapy for metastatic pancreatic cancer: single choice or sequence	ANNALS OF ONCOLOGY	2017